Hilton Capital Management, LLC Novo Nordisk A S Transaction History

Hilton Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$122.71 - $146.91 $394,880 - $472,756	3,218 Added 5.45%	62,269 $8.89 Million
Q1 2024 May 10, 2024	SELL	$102.11 - $135.92 $12,253 - $16,310	-120 Reduced 0.2%	59,051 $7.58 Million
Q4 2023 Feb 09, 2024	BUY	$87.78 - $105.45 $1,053 - $1,265	12 Added 0.02%	59,171 $6.12 Million
Q3 2023 Nov 13, 2023	BUY	$90.94 - $199.54 $2.6 Million - $5.7 Million	28,571 Added 93.41%	59,159 $5.38 Million
Q2 2023 Jul 31, 2023	BUY	$155.98 - $172.65 $4.77 Million - $5.28 Million	30,588 New	30,588 $4.95 Million

1,954

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $236B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Hilton Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Hilton Capital Management, LLC with notifications on news.